Royal Bank of Canada

Selected news for the capital firm - Royal Bank of Canada, collected since 10/2017. Recent stories appear in Benzinga and rivertonroll.com. This capital firm shares healthcare news with Benefitfocus, Mental Health, iRhythm, Varian Medical Systems and dozens of others.

Please provide a valid email address.
Shares Healthcare News With (link):
Healthcare Topics
Companies
Health Systems

Selected Headines

Date Headline (link) Source Relevant Snippet
2/23/2021 Analysts’ Recent Ratings Changes for Healthcare Services Group (HCSG) rivertonroll.com ... and responsive, our people are trained to help you achieve success by delivering innovative solutions, exceptional performance and measurable results. “ 2/11/2021 – Healthcare Services Group had its price target raised by analysts at Royal Bank of Canada from $24.00 to $30.00. They now have a “sector perform” rating on the stock. 2/11/2021 – Healthcare Services Group had its price target lowered by analysts at Credit Suisse Group AG ...
2/23/2021 Q1 2021 EPS Estimates for Healthcare Services Group, Inc. Cut by Analyst (NASDAQ:HCSG) Daily Political ... brokerages have also recently commented on HCSG. Zacks Investment Research cut shares of Healthcare Services Group from a “buy” rating to a “hold” rating in a research note on Friday, February 12th. Royal Bank of Canada lifted their target price on Healthcare Services Group from $24.00 to $30.00 and gave the company a “sector perform” rating in a research report on Thursday, February 11th. TheStreet upgraded shares ...
2/22/2021 eHealth (NASDAQ:EHTH) Downgraded by Deutsche Bank Aktiengesellschaft dispatchtribunal.com ... Targets.com reports. They currently have $63.00 target price on the financial services provider’s stock, down from their previous target price of $124.00.Other equities analysts have also issued research reports about the stock. Royal Bank of Canada lowered shares of eHealth from an outperform rating to a sector perform rating in a research report on Friday, January 29th. The Goldman Sachs Group cut their price objective on shares of ...
2/22/2021 Colliers Securities Comments on R1 RCM Inc.'s Q1 2021 Earnings (NASDAQ:RCM) rivertonroll.com ... to a “strong sell” rating in a research note on Friday, January 8th. KeyCorp raised their target price on R1 RCM from $27.00 to $35.00 in a research note on Tuesday, February 16th. Royal Bank of Canada lifted their price objective on R1 RCM from $20.00 to $27.00 and gave the company an “outperform” rating in a research note on Wednesday, December 9th. Finally, SVB Leerink lifted their ...
2/22/2021 Bausch Health Companies (BHC) Scheduled to Post Quarterly Earnings on Wednesday zolmax.com ... 33.58 and its 200-day simple moving average is C$25.98. The company has a market capitalization of C$14.31 billion and a P/E ratio of -7.41. Get Bausch Health Companies alerts:Separately, Royal Bank of Canada upped their price target on Bausch Health Companies to C$42.00 and gave the stock a “na” rating in a research note on Thursday. Bausch Health Companies Company ProfileBausch Health ...
2/22/2021 Andlauer Healthcare Group Inc. (AND.TO) (TSE:AND) PT Lowered to C$38.50 at Scotiabank dispatchtribunal.com ... on the company. National Bank Financial reaffirmed a sector perform rating and issued a C$36.25 price target on shares of Andlauer Healthcare Group Inc. (AND.TO) in a research note on Friday, February 12th. Royal Bank of Canada upped their price target on Andlauer Healthcare Group Inc. (AND.TO) from C$50.00 to C$51.00 and gave the stock an outperform rating in a research note on Thursday, November 12th. Get ...
2/22/2021 Research Analysts Issue Forecasts for Andlauer Healthcare Group Inc. (AND.TO)'s Q4 2020 Earnings (TSE:AND) baseballnewssource.com ... research analysts have also recently issued reports on AND. Scotiabank dropped their target price on shares of Andlauer Healthcare Group Inc. (AND.TO) from C$45.00 to C$38.50 in a research report on Friday. Royal Bank of Canada increased their target price on shares of Andlauer Healthcare Group Inc. (AND.TO) from C$50.00 to C$51.00 and gave the stock an “outperform” rating in a research report on Thursday ...
2/22/2021 Andlauer Healthcare Group Inc. (AND.TO) (TSE:AND) to Post Q4 2020 Earnings of $0.24 Per Share, National Bank Financial Forecasts com-unik.info ... National Bank Financial currently has a “Sector Perform Market Weight” rating on the stock. Get Andlauer Healthcare Group Inc. (AND.TO) alerts:A number of other equities analysts also recently weighed in on AND. Royal Bank of Canada increased their price target on shares of Andlauer Healthcare Group Inc. (AND.TO) from C$50.00 to C$51.00 and gave the stock an “outperform” rating in a research note on Thursday ...
2/21/2021 eHealth (NASDAQ:EHTH) Rating Lowered to Hold at Deutsche Bank Aktiengesellschaft Daily Political ... of 9.22% from the company’s previous close.Several other analysts have also issued reports on EHTH. Truist reduced their target price on eHealth from $200.00 to $100.00 in a report on Monday, February 1st. Royal Bank of Canada lowered eHealth from an “outperform” rating to a “sector perform” rating in a report on Friday, January 29th. SVB Leerink reduced their target price on eHealth from $110.00 to $105.00 ...
2/21/2021 Q2 2021 Forecast for Healthcare Services Group, Inc. Issued By William Blair (NASDAQ:HCSG) Daily Political ... Credit Suisse Group reduced their price target on shares of Healthcare Services Group from $32.00 to $31.00 and set a “neutral” rating for the company in a research report on Thursday, February 11th. Royal Bank of Canada upped their target price on shares of Healthcare Services Group from $24.00 to $30.00 and gave the company a “sector perform” rating in a report on Thursday, February 11th. Finally, Zacks ...
2/20/2021 Biogen (NASDAQ:BIIB) Price Target Lowered to $268.00 at Cantor Fitzgerald Ticker Report ... rating on the biotechnology company’s stock. Cantor Fitzgerald also issued estimates for Biogen’s FY2021 earnings at $19.24 EPS.A number of other equities research analysts have also recently commented on the company. Royal Bank of Canada increased their price target on Biogen from $249.00 to $256.00 and gave the company a sector perform rating in a research note on Tuesday, December 1st. Piper Sandler decreased their price target ...
2/18/2021 BioCryst Pharmaceuticals (NASDAQ:BCRX) Upgraded at Zacks Investment Research baseballnewssource.com ... the topic of several other reports. Evercore ISI initiated coverage on BioCryst Pharmaceuticals in a research note on Monday, November 23rd. They set an outperform rating and a $12.00 price objective on the stock. Royal Bank of Canada boosted their target price on BioCryst Pharmaceuticals from $7.00 to $9.00 and gave the company a sector perform rating in a research report on Friday, January 22nd. HC Wainwright boosted their target ...
2/18/2021 The Financial Symptoms of Dementia: When Missed Payments Could Be a Cognitive Health Red Flag beingpatient.com ... something was surely wrong. He was diagnosed with Alzheimer’s shortly after.“He showed early warning signs of dementia that we should have picked up sooner,” O’Leary, head of wealth planning at Royal Bank of Canada Wealth Management-U.S., told Being Patient. “They were very financial-related: bills not paid, lots of stuff piling up, bills paid twice, filing the wrong tax returns, a whole bunch of those ...
2/18/2021 Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Earns “Buy” Rating from UBS Group baseballnewssource.com ... Co. KGaA in a research report on Tuesday, February 2nd. DZ Bank reaffirmed a buy rating on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Wednesday, February 3rd. Finally, Royal Bank of Canada reissued a neutral rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Thursday, November 19th. One investment analyst has rated the stock with a sell rating, nine ...
2/18/2021 AdaptHealth Corp. (NASDAQ:AHCO) Receives $42.06 Consensus Target Price from Analysts slatersentinel.com ... recently commented on AHCO. Deutsche Bank Aktiengesellschaft lifted their price target on shares of AdaptHealth from $36.00 to $47.00 and gave the stock a “buy” rating in a report on Friday, December 4th. Royal Bank of Canada lifted their price target on shares of AdaptHealth from $36.00 to $50.00 and gave the stock an “outperform” rating in a report on Wednesday, December 2nd. Bank of America began coverage ...
2/18/2021 bluebird bio (NASDAQ:BLUE) Price Target Raised to $56.00 at BMO Capital Markets zolmax.com ... Wednesday, November 11th. Canaccord Genuity decreased their target price on shares of bluebird bio from $118.00 to $86.00 and set a buy rating for the company in a research report on Thursday, November 5th. Royal Bank of Canada cut shares of bluebird bio from an outperform rating to a sector perform rating in a research report on Wednesday. Oppenheimer cut shares of bluebird bio from an outperform rating to a ...
2/17/2021 Pro Medicus Limited (OTCMKTS:PMCUF) Up 45.9% in January Daily Political ... 50 day moving average price of $29.99 and a two-hundred day moving average price of $23.20. Pro Medicus has a 12-month low of $8.30 and a 12-month high of $35.49. Separately, Royal Bank of Canada cut shares of Pro Medicus from an “outperform” rating to a “sector perform” rating in a research note on Wednesday, January 13th. Pro Medicus Company Profile Pro Medicus Limited provides ...
2/16/2021 Alphabet (NASDAQ:GOOG) Sets New 1-Year High at $2,140.55 American Banking News ... number of recent research reports. Mizuho increased their price objective on shares of Alphabet from $2,100.00 to $2,350.00 and gave the company a “buy” rating in a research note on Wednesday, February 3rd. Royal Bank of Canada reiterated a “buy” rating on shares of Alphabet in a research report on Friday, October 30th. Citigroup reissued a “buy” rating on shares of Alphabet in a report on Friday ...
2/16/2021 HealthEquity (HQY) ‚Äì Investment Analysts‚Äô Recent Ratings Changes Ticker Report ... Äúoutperform‚Äù rating reaffirmed by analysts at Barrington Research. They now have a $90.00 price target on the stock, up previously from $75.00. 2/9/2021 ‚Äì HealthEquity had its price target raised by analysts at Royal Bank of Canada from $74.00 to $87.00. They now have an ‚Äúoutperform‚Äù rating on the stock. 2/9/2021 ‚Äì HealthEquity had its price target raised by analysts at Truist Financial Co. from $80.00 to $92.00 ...
2/15/2021 National Bank Financial Upgrades Andlauer Healthcare Group Inc. (AND.TO) (TSE:AND) to Sector Perform zolmax.com ... perform rating in a report published on Friday, BayStreet.CA reports. The firm currently has C$36.25 price objective on the stock.A number of other equities research analysts have also issued reports on AND. Royal Bank of Canada increased their price target on Andlauer Healthcare Group Inc. (AND.TO) from C$50.00 to C$51.00 and gave the stock an outperform rating in a research note on Thursday, November 12th. Scotiabank ...